About Us
Company Overview
Bionostix is a German clinical diagnostics and laboratory systems manufacturer specializing in precision in-vitro diagnostic systems for global laboratory markets.
​
The company operates industrial production facilities in Badr City, Egypt, combining German scientific leadership with large-scale manufacturing capabilities.
​
Company Structure
-
Corporate Headquarters — Germany
-
Manufacturing Operations — Egypt
-
Global Distribution — International
Prof. Alaa Barakat, CEO
Prof. Alaa Barakat, Ph.D., is Chief Executive Officer of Bionostix, overseeing the company’s global diagnostics manufacturing operations and strategic development across life science technologies.
Trained in molecular medicine and biochemistry at Humboldt University Berlin and the Free University of Berlin, he combines scientific expertise with industrial leadership across international pharmaceutical and biotechnology environments. In parallel with his executive role, he serves as Chair of the Department of Biochemistry and Biotechnology at Heliopolis University for Sustainable Development.
Bionostix develops and manufactures in-vitro diagnostic reagents across multiple application areas, including immunoassays, hematology reagents, urine diagnostics, and analytical chemistry–based solutions.
The company operates as both a manufacturer and development partner, supporting legal manufacturers and distribution partners through formulation development, process optimization, and controlled production under an ISO 13485–certified quality management system.
Bionostix’s role is focused on transforming diagnostic concepts into reproducible, scalable manufacturing processes suitable for routine laboratory use.
What We Do
Regulatory and Manufacturing Role
Bionostix manufactures in-vitro diagnostic products in alignment with applicable regulatory requirements and acts as an approved manufacturing site for selected CE-marked products under the In Vitro Diagnostic Directive (IVDD), where the legal manufacturer holds market responsibility.
This manufacturing-focused role allows Bionostix to support regulated market supply while maintaining clear separation between production activities and legal manufacturer obligations.
​
Today, Bionostix’s core activities are centered on IVD manufacturing and development support. Building on this foundation, the company continues to strengthen its technical capabilities and production infrastructure in line with evolving regulatory standards and long-term diagnostic market needs.